Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

On-Line Patient Portal Use By Caregivers in Pediatric Oncology: Are We Widening Sociodemographic Disparities?

Corinna L Schultz, MD, Suzanne M McCahan, PhD, H. Timothy Bunnell, PhD, Fang Fang Chen, PhD, Melissa A Alderfer, PhD

Blood (2019) 134 (Supplement_1): 2131.

https://doi.org/10.1182/blood-2019-131543

Published: 2019

Journal Articles

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

Abby Statler, PhDMPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Caitlin Siebenaller, PharmD, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS

Blood (2019) 134 (Supplement_1): 3836.

https://doi.org/10.1182/blood-2019-128853

Published: 2019

Journal Articles

Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB Study

Hussain I Rangoonwala, MBBS, Jonathan Gootee, MD, Peter T. Silberstein, MD

Blood (2019) 134 (Supplement_1): 3840.

https://doi.org/10.1182/blood-2019-131233

Published: 2019

Journal Articles

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Robert F. Sidonio, Jr., MD MSc, Dunlei Cheng, PhD, Christine Guelcher, PPCNP-BC, Janna M. Journeycake, MD, Susan U Lattimore, Clifford Takemoto, MD, Michael D. Tarantino, MD, Crystal Watson, Ellis J. Neufeld, MD, Carol Fedor, RN

Blood (2019) 134 (Supplement_1): 1114.

https://doi.org/10.1182/blood-2019-128612

Published: 2019

Journal Articles

Health Insurance Status Impacts Rates of Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia

Jeremy Chang, MD, Sherry Zhang, MD, Mojtaba Akhtari, MD

Blood (2019) 134 (Supplement_1): 2581.

https://doi.org/10.1182/blood-2019-123738

Published: 2019

Journal Articles

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Lynn M. Malec, MD, Gilbert C. White, MD, Stacy E. Croteau, MD, Dunlei Cheng, PhD, Margaret V. Ragni, MD MPH

Blood (2018) 132 (Supplement 1): 2467.

https://doi.org/10.1182/blood-2018-99-115231

Published: 2018

Journal Articles

Payment Plans Bridging Gap: An Equalizer for the Hispanic Population with Lymphoid Neoplasms in a Majority-Minority Community

Jessica Trevino Jones, MD, Sushanth Kakarla, MBBS, Annie Hung, MD, Michelle Janania Martinez, MD, Prathibha Surapaneni, Juan Garza, MD, David Gregorio, MD, Elva Nora Osuna Salazar, MD, Joel E Michalek, PhD, Qianqian Liu, MS, Adolfo E Diaz, MD

Blood (2018) 132 (Supplement 1): 2303.

https://doi.org/10.1182/blood-2018-99-115184

Published: 2018

Journal Articles

Worse Outcomes Associated with Public Insurance in AYAs with Leukemia and Lymphoma

Elysia Alvarez, MD MPH, Helen Parsons, Frances Maguire, Yi Chen, Cyllene Morris, Arti Parikh-Patel, Ted Wun, MD, Theresa H.M. Keegan, PhD MS

Blood (2018) 132 (Supplement 1): 977.

https://doi.org/10.1182/blood-2018-99-115519

Published: 2018

Journal Articles

Disparities in survival by insurance status in follicular lymphoma

Jordan S. Goldstein, Loretta J. Nastoupil, Xuesong Han, Ahmedin Jemal, Elizabeth Ward, Christopher R. Flowers

Blood (2018) 132 (11): 1159–1166.

https://doi.org/10.1182/blood-2018-03-839035

Published: 2018

Includes: Supplemental data

Journal Articles

Real-World Testing and Treatment Patterns in Chronic Lymphocytic Leukemia (CLL) in the United States during the Modern Era: A SEER Patterns of Care Analysis

Erlene K. Seymour, MDBS, Julie J. Ruterbusch, M.P.H., Jennifer L. Beebe-Dimmer, PhD, M.P.H., Charles A. Schiffer, MD

Blood (2017) 130 (Supplement 1): 3384.

https://doi.org/10.1182/blood.V130.Suppl_1.3384.3384

Published: 2017

Journal Articles

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

Sikander Ailawadhi, Ryan D. Frank, Nicolette T. Chimato, Zahara Meghji, Raj Patel, MD, Prachi Jani, MD, Tanya S. Kakar, Mark A. Fiala, BS, Sonikpreet Aulakh, MD, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD FACP, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 860.

https://doi.org/10.1182/blood.V130.Suppl_1.860.860

Published: 2017

Journal Articles

Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA)

Andrea Sitlinger, MD, Rishi Sachdev, David Anderson, BS/MS, S. Yousuf Zafar, MD MHS

Blood (2017) 130 (Supplement 1): 4680.

https://doi.org/10.1182/blood.V130.Suppl_1.4680.4680

Published: 2017

Journal Articles

Practice Patterns of Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Lymphoblastic Leukemia (ALL)

Jayadev Manikkam Umakanthan, MBBS, Baojiang Chen, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MD

Blood (2017) 130 (Supplement 1): 5013.

https://doi.org/10.1182/blood.V130.Suppl_1.5013.5013

Published: 2017

Journal Articles

Statewide Geographic Variation and Impact of Center Expertise upon Outcomes for Adults with Acute Myeloid Leukemia (AML) in North Carolina

Ashley T Freeman, MD, Anne Marie Meyer, PhD, Andrew B Smitherman, MD, Lei Zhou, MSPH, Ethan M Basch, MD MSc, Thomas C. Shea, MD, William A. Wood, MD MPH

Blood (2015) 126 (23): 4479.

https://doi.org/10.1182/blood.V126.23.4479.4479

Published: 2015

Journal Articles

Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)

Smith Giri, MBBS, Valerie Shostrom, MS, Krishna Gundabolu, MD, KM Monirul Islam, MDPhD, Ranjan Pathak, MD, Lori J. Maness, MD, Vijaya R. Bhatt, MD

Blood (2015) 126 (23): 533.

https://doi.org/10.1182/blood.V126.23.533.533

Published: 2015

Journal Articles

Comparison Between Saddle Versus Non-Saddle Pulmonary Embolism: Insights from Nationwide Inpatient Sample

Ranjan Pathak, MD, Smith Giri, MD, Madan Raj Aryal, MD, Paras Karmacharya, MD, Anthony A Donato, MDMHPE

Blood (2014) 124 (21): 3514.

https://doi.org/10.1182/blood.V124.21.3514.3514

Published: 2014

Journal Articles

Patterns of Care in a Random Population-Based Sample of Patients Diagnosed with CLL.

Thomas A. Davis, MD, Limin X. Clegg, Ph.D., Jennifer L. Stevens, BS, Linda C. Harlan, Ph.D.

Blood (2004) 104 (11): 86.

https://doi.org/10.1182/blood.V104.11.86.86

Published: 2004

NARROW

On-Line Patient Portal Use By Caregivers in Pediatric Oncology: Are We Widening Sociodemographic Disparities?

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB Study

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Health Insurance Status Impacts Rates of Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Payment Plans Bridging Gap: An Equalizer for the Hispanic Population with Lymphoid Neoplasms in a Majority-Minority Community

Worse Outcomes Associated with Public Insurance in AYAs with Leukemia and Lymphoma

Disparities in survival by insurance status in follicular lymphoma

Real-World Testing and Treatment Patterns in Chronic Lymphocytic Leukemia (CLL) in the United States during the Modern Era: A SEER Patterns of Care Analysis

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA)

Practice Patterns of Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Lymphoblastic Leukemia (ALL)

Statewide Geographic Variation and Impact of Center Expertise upon Outcomes for Adults with Acute Myeloid Leukemia (AML) in North Carolina

Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)

Comparison Between Saddle Versus Non-Saddle Pulmonary Embolism: Insights from Nationwide Inpatient Sample

Patterns of Care in a Random Population-Based Sample of Patients Diagnosed with CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only